MedPath

This is an observational study conducted to observe how subjects with dizziness and dizziness associated symptoms are managed in primary care setting in India.

Not Applicable
Completed
Conditions
Health Condition 1: G89-G99- Other disorders of the nervous system
Registration Number
CTRI/2018/11/016408
Lead Sponsor
Abbott Healthcare Private Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1000
Inclusion Criteria

1.Adult male and female patients (aged >=18 years) presenting with dizziness in primary care

2.Patients willing to participate in the registry and provide informed consent for participation

3.Patients who are willing and competent to sign and date a patient authorization form (PAF) for participation in the study

Exclusion Criteria

1.Pregnant and lactating women

2.Patients with dizziness requiring hospitalization for any cause

3.Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine clinicoepidemiological profile of patients presenting with dizziness in the primary care setting <br/ ><br>Timepoint: 1. Base to Week 1 <br/ ><br>2. Baseline to Week4
Secondary Outcome Measures
NameTimeMethod
Management practices <br/ ><br>a. Number and percentage of patients advised to undergo routine assessments/advanced <br/ ><br>assessments <br/ ><br>b. Number and percentage of patients being advised lifestyle modification (change in <br/ ><br>smoking habit/alcohol consumption/diet/exercise/both), and/or pharmacotherapy (betahistine, <br/ ><br>prochlorperazine and cinnarizine monotherapy, and cinnarizine fixed dose combination <br/ ><br>therapy) and/or referred to specialists for further managementTimepoint: Number and percentage of patients advised for advanced assessment or lifestyle modification -From 1. Baseline to week1 , 2. Week1 and week4. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath